Vascular invasion in hepatocellular carcinoma: Is there a correlation with MRI?

British Journal of Radiology

Volumn 85, Issue 1014, 2012, Pages 736-744

  Griffin, Nyree ^a   Addley, H ^b   Sala, E ^b   Shaw, A S ^b   Grant, L A ^b   Eldaly, H ^b   Davies, S E ^b   Prevost, T ^b   Alexander, G J ^b   Lomas, D J ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; VASCULAR NEOPLASMS;

EID: 84861896042     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/94924398     Document Type: Article

References (38)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50. (Pubitemid 29114292)
2. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology 1998;45:1281-7. (Pubitemid 28372114)
3. Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, et al. Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 1996;83:758-61. (Pubitemid 26175080)
4. Baccarani U, Benzoni E, Adani GL, Benzoni E, Avellini C, Lorenzin D, et al. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transplant Proc 2007;39:1898-900. (Pubitemid 47198809)
5. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30:6-25. (Pubitemid 44900485)
6. Choi D, Lim HK, Joh JW, Kim SJ, Kim MJ, Rhim H, et al. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann Surg Oncol 2007;14:3510-18. (Pubitemid 350160100)
7. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer 2001;91:2378-85. (Pubitemid 32552825)
8. Butterfield LH. Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 2004;127:S232-41. (Pubitemid 39423392)
9. Llovet J, Ricci S, Mazzaferro V, Hilgard P, Raoul J, Zeuzem S, et al. Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a Phase III randomized placebo-controlled trial (SHARP trial). Proceedings of the ASCO Annual Meeting. J Clin Oncol 2007;(Part I.)25:18S.
10. 1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology 2006;239:438-47.
11. Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al. MRI angiography is superior to helical CT for the detection of HCC prior to liver transplantation: an explants correlation. Hepatology 2003;38:1034-42. (Pubitemid 37221687)
12. Krinsky GA, Lee VS, Thiese ND, Weinreb JC, Rofsky NM, Diflo T, et al. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explants correlation. Radiology 2001;219:445-54. (Pubitemid 32336360)
13. Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, et al. Small nodule detection in cirrhotic livers: evaluation with US, spiral CT and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 2001;25:327-36. (Pubitemid 32440782)
14. Pérez-Saborido B, de los Galanes SJ, Menéu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, et al. Tumour recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors. Transplant Proc 2007;39:2304-7. (Pubitemid 47418167)
15. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002;8:237-42.
16. Nanashima A, Abo T, Sumida Y, Takeshita H, Hidaka S, Furukawa K, et al. Clinicopathological characteristics of patients with hepatocellular carcinoma after hepatectomy: relationship with status of viral hepatitis. J Surg Oncol 2007;96:487-92. (Pubitemid 350044392)
17. Tangkijavanich P, Anukulkarnkusol N, Suqangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha fetoprotein levels. J Clin Gastroenterol 2000;31:302-8.
18. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389-94.
19. Hussain SM, Sondervan PE, Ijzermans JNM, Schalm SW, de Man RA, Krestin G. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002;22:1023-39.
20. van den Bos IC, Hussain SM, de Man RA, Zondervan PE, Ijzermans JN, Krestin GP. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation. Curr Probl Diagn Radiol 2008;37:104-14. (Pubitemid 351541462)
21. 2- weighted breath-hold fast spin-echo sequences and highresolution dynamic MR imaging with a phased-array body coil. J Magn Reson Imaging 1999;9:274-9.
22. 2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 2004;230:637-44.
23. 2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol 2007;67: 304-10.
24. Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana R, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially enhancing liver mass. Liver Transpl 2005;11:281-9. (Pubitemid 40458400)
25. Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis; enhancement patterns at dynamic gadolinium and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 2005;237:520-8. (Pubitemid 41507889)
26. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, et al. Characterisation of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005;42:27-34. (Pubitemid 40911308)
27. van den Bos IC, Hussain SM, Dwarkasing RS, Hop WC, Zondervan PE, de Man RA, et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007;26:1548-55. (Pubitemid 350291283)
28. Miyata R, Tanimoto A, Wakabayashi G, Shimazu M, Nakatsuka S, Mukai M, et al. Accuracy of preoperative prediction of microinvasion of portal vein in hepatocellular carcinoma using superparamagnetic iron oxide-enhanced magnetic resonance imaging and computed tomography during hepatic angiography. J Gastroenterol 2006;41:987-95. (Pubitemid 44741412)
29. Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 2009;250:435-43.
30. Kajiwara M. MR imaging of small hepatocellular carcinoma (< or = 20 mm) - correlation with vascularity and histological features. Kurume Med J 1997;44:327-38. (Pubitemid 128516382)
31. Nishie A, Yoshimitsu K, Asayama Y, Irie H, Tajima T, Hirakawa M, et al. Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol 2008;190:81-7.
32. Nishie A, Yoshimitsu K, Irie H, Tajima T, Hirakawa M, Ishigami K, et al. Radiological detectability of minute hepatic venous invasion in hepatocellular carcinoma. Eur J Radiol 2009;70:517-24.
33. Shirabe K,Kajiyama K,Abe T, Sakamoto S, Fukuya T, Akazawa K, et al. Predictors of microscopic portal vein invasion by hepatocellular carcinoma: measurement of portal perfusion defect area ratio. J Gastroenterol Hepatol 2009;24:1431-6.
34. Abdel-Wahab M, El-Husseiny TS, El Hanafy E, El Shobary M, Hamdy E. Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Langenbecks Arch Surg. 2010; 395: 625-32.
35. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007;141:330-9. (Pubitemid 46371307)
36. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 2003;197:753-8. (Pubitemid 38199576)
37. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006;202:275-83. (Pubitemid 43112487)
38. Muhi A, Ichikawa T, Motosugi U, Sano K, Matsuda M, Kitamura T, et al. High-b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging 2009;30:1005-11.